Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?

Antonio Daniele; Francesco Panza; Madia Lozupone; Vittorio Dibello; Antonio Greco; Davide Seripa; Giancarlo Logroscino; Bruno P Imbimbo

doi:10.2217/imt-2018-0119

Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?

Antonio Daniele, Francesco Panza, Madia Lozupone, Vittorio Dibello, Antonio Greco, Davide Seripa, Giancarlo Logroscino, Bruno P Imbimbo

Risultato della ricerca: Contributo in rivista › Articolo in rivista

29 Citazioni (Scopus)

Abstract

N/A

Lingua originale	English
pagine (da-a)	3-6
Numero di pagine	4
Rivista	Immunotherapy
Volume	11
DOI	https://doi.org/10.2217/imt-2018-0119
Stato di pubblicazione	Pubblicato - 2019

Keywords

Alzheimer's disease
BAN2401
Immunology
Immunology and Allergy
MCI
Oncology
aducanumab
dementia
monoclonal antibodies
passive immunotherapy
prodromal Alzheimer's disease

Accesso al documento

10.2217/imt-2018-0119

Altri file e collegamenti

Cita questo

@article{441815d31d78455dbab41112322e433a,

title = "Are antibodies directed against amyloid-β (Aβ) oligomers the last call for the Aβ hypothesis of Alzheimer's disease?",

abstract = "N/A",

keywords = "Alzheimer's disease, BAN2401, Immunology, Immunology and Allergy, MCI, Oncology, aducanumab, dementia, monoclonal antibodies, passive immunotherapy, prodromal Alzheimer's disease, Alzheimer's disease, BAN2401, Immunology, Immunology and Allergy, MCI, Oncology, aducanumab, dementia, monoclonal antibodies, passive immunotherapy, prodromal Alzheimer's disease",

author = "Antonio Daniele and Francesco Panza and Madia Lozupone and Vittorio Dibello and Antonio Greco and Davide Seripa and Giancarlo Logroscino and Imbimbo, {Bruno P}",

year = "2019",

doi = "10.2217/imt-2018-0119",

language = "English",

volume = "11",

pages = "3--6",

journal = "Immunotherapy",

issn = "1750-743X",

publisher = "London : Future Medicine, 2009-",

}